Related Experiment Video
Updated: Jun 23, 2026

LipidUNet-Machine Learning-Based Method of Characterization and Quantification of Lipid Deposits Using iPSC-Derived Retinal Pigment Epithelium
Published on: July 28, 2023
Current and future therapies for age-related macular degeneration
Julia Beutel1, Martin Rudolf, Salvatore Grisanti
1University of Lübeck, University Eye Hospital, Lübeck, Germany.
Background:
Age-related macular degeneration is the leading cause of blindness, with an increasing incidence as the elderly population expands.
Objective:
In this article we review current therapeutic strategies and discuss possible future targets.
Methods:
A review of the literature and ongoing clinical trials was undertaken.
Results:
Currently, established therapies for neovascular AMD-like photodynamic therapy and anti-VEGF therapies allow stabilization or even improvement of vision. Potential future drugs under development for advanced AMD or its prevention target the signal transduction cascade of different angiogenic molecules. These drugs intervene at different levels of the involved processes including the RNA production and specific protein expression as well as inflammatory, apoptotic, or metabolic processes.
Conclusion:
Combining different strategies targeting angiogenesis, inflammation and apoptosis, or interfering early in--or even prior to--the formation of choroidal neovascularization, may improve the future management of age-related macular degeneration.
More Related Videos
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
05:14Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography
Published on: August 11, 2023
Related Concept Videos
iPS Cell Differentiation
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Diabetic Retinopathy